Mobile

A study to look at the safety, tolerability and efficacy of repeated doses of different concentrations of the study drug during controlled inhalation of allergens in adult asthmatics

Mise à jour : Il y a 4 ans
Référence : EUCTR2012-001483-29

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To determine the effect of CHF6001 DPI in attenuating the late asthmatic response (LAR) after an allergen challenge (AC) following 9 days of inhaled dosing in adult patients with allergic asthma.

Critère d'inclusion

  • Asthma

Liens